{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:05Z","timestamp":1787578505264,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate prediagnostic endometrial thickness measured by transvaginal ultrasonography (TVUS) in a cohort of patients with endometrial cancer stratified by p53 status to assess accuracy of endometrial thickness as a screening tool in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of patients diagnosed with endometrial cancer who underwent prediagnostic TVUS between 2004 and 2017. Using a tissue microarray, we categorized cases as p53 abnormal (p53abn) or p53 wild type (p53wt) according to the presence or absence of p53 aberrant immunohistochemistry staining. Cases were stratified according to established screening thresholds of 4-mm or less endometrial thickness used to evaluate postmenopausal bleeding. Clinical data were manually abstracted. All patients included underwent surgical staging, including hysterectomy. Student\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      , \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      , and Fisher exact tests were performed to assess for variables associated with p53abn endometrial carcinoma. Multivariate logistic regression was performed to assess variables associated with cases of endometrial cancer, with\n                      <jats:italic toggle=\"yes\">false-negative TVUS screening results<\/jats:italic>\n                      defined as an endometrial thickness of 4 mm or less.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of the 133 patients identified, 60 (45.1%) were classified as p53abn and 73 (54.9%) as p53wt. The median age of the cohort was 66 years (interquartile range 58\u201374 years), and median body mass index (BMI) was 31.3 (interquartile range 26.8\u201337.3). Median endometrial thickness was 16 mm (interquartile range 9\u201322 mm), and 48 patients (36.1%) had submucosal or intramural leiomyomas identified on TVUS. Patients diagnosed with p53abn endometrial cancers were more likely to have thinner endometrial measurements compared with p53wt cases (10 mm [interquartile range 5\u201318.5 mm] vs 18 mm [interquartile range 13\u201323 mm],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). At a threshold of 4 mm or less, patients with p53abn endometrial cancer were more likely to screen negative compared with patients with p53wt endometrial cancer (25% vs 4.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). In multivariate analysis, a threshold of 4 mm or less for endometrial thickness, lower BMI (odds ratio [OR] 0.906, 95% CI, 0.833\u20130.986,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.023), and p53 status (OR 9.415, 95% CI, 2.441\u201336.309,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.001) remained significant predictors of false-negative screening results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Endometrial thickness assessed by TVUS does not appear to be a reliable screening method in patients diagnosed with p53abn endometrial cancers. The use of endometrial thickness as a screening test for endometrial cancer may miss a significant portion of p53abn cases because of false-negative results. In the presence of postmenopausal bleeding, endometrial tissue sampling should be strongly considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006074","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T21:00:30Z","timestamp":1759438830000},"page":"881-887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Ultrasonography-Based Measurements of Endometrial Thickness in Patients With p53 Abnormal Endometrial Carcinomas"],"prefix":"10.1097","volume":"146","author":[{"given":"Matthew K.","family":"Wagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Mojdehbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Reetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed N.","family":"Al-Niaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Gontarczyk","family":"Uczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Godecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Barroilhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"R1-20260824","first-page":"12","article-title":"Cancer statistics, 2024 [published erratum appears in CA Cancer J Clin 2024;74:203","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamainternmed.2018.2820","article-title":"Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis","volume":"178","author":"Clarke","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","article-title":"Endometrial cancer: a review and current management strategies: part I","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/AOG.0000000000002631","article-title":"The role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. ACOG Committee Opinion No. 734. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2020.01.032","article-title":"Ultrasound detection of endometrial cancer in women with postmenopausal bleeding: systematic review and meta-analysis","volume":"157","author":"Long","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"549.e1","DOI":"10.1016\/j.ajog.2020.03.032","article-title":"Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms","volume":"223","author":"Clarke","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamaoncol.2024.1891","article-title":"Endometrial thickness as diagnostic triage for endometrial cancer among Black individuals","volume":"10","author":"Doll","year":"2024","journal-title":"JAMA Oncol"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaoncol.2021.1700","article-title":"Estimated performance of transvaginal ultrasonography for evaluation of postmenopausal bleeding in a simulated cohort of Black and White women in the US","volume":"7","author":"Doll","year":"2021","journal-title":"JAMA Oncol"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype","volume":"8","author":"Clarke","year":"2022","journal-title":"JAMA Oncol"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2012.09.012","article-title":"Uterine papillary serous cancer: a review of the literature","volume":"127","author":"Del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/PGP.0000000000000783","article-title":"HER2 expression in endometrial cancers diagnosed as clear cell carcinoma","volume":"41","author":"Cagaanan","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0002-9378(95)90483-2","article-title":"Gynecology transvaginal ultrasonography of the endometrium women with postmenopausal bleeding\u2014a Nordic multicenter study","volume":"172","author":"Karlsson","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1469-0705.1996.07050315.x","article-title":"Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding: an Italian multicenter study","volume":"7","author":"Ferrazzi","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1471-0528.13438","article-title":"Transvaginal ultrasound measurement of the endometrium remains the first line test for investigating postmenopausal bleeding but integration of patient characteristics into testing may further improve diagnostic algorithms","volume":"123","author":"Breijer","year":"2016","journal-title":"BJOG"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1067\/mob.2003.154","article-title":"Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer","volume":"188","author":"Gull","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/IGC.0000000000000423","article-title":"The use of transvaginal ultrasound in type II endometrial cancer","volume":"25","author":"Billingsley","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R19-20260824","first-page":"1133","article-title":"Ultrasonographic evaluation of endometrial stripe thickness is insufficient to rule out uterine serous carcinoma","volume":"34","author":"Kiff","year":"2023","journal-title":"Cancer Causes Control"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2022.04.014","article-title":"Molecular profiles of endometrial cancer tumors among Black patients","volume":"166","author":"Wilhite","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u201cmultiple-classifier\u201d endometrial carcinomas","volume":"250","author":"Le\u00f3n\u2010Castillo","year":"2020","journal-title":"J Pathol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:12:40Z","timestamp":1787577160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006074","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"2025-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}